Average Co-Inventor Count = 6.43
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (7 from 4,948 patents)
2. Bristol-Myers Squibb Compnay (6 from 3,687 patents)
3. Roche Innovation Center Copenhagen A/s (5 from 46 patents)
4. F. Hoffmann-La Roche Ag (2 from 168 patents)
5. Genentech, Inc. (1 from 3,224 patents)
6. Leo-Pharma A/s (67 patents)
7. Exiqon A/s (30 patents)
8. Rigshospitalet (18 patents)
9. Copenhagen University (1 patent)
10. Gentofte Hospital (0 patent)
17 patents:
1. 12241065 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof
2. 12180478 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof
3. 12163131 - Oligonucleotides for modulating Tau expression
4. 11761951 - Methods of selecting therapeutic molecules
5. 11753640 - Oligonucleotides for modulating Tau expression
6. 11542501 - Antisense oligonucleotides targeting ATXN3
7. 11485975 - Oligonucleotides for modulating TMEM106B expression
8. 11447775 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof
9. 11359197 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof
10. 11286485 - Oligonucleotides for modulating ATXN2 expression
11. 11279929 - Oligonucleotides for modulating Tau expression
12. 11077132 - Tau antisense oligomers and uses thereof
13. 11066669 - Oligonucleotides for modulating ATXN2 expression
14. 11058767 - CAMK2D antisense oligonucleotides and uses thereof
15. 10815481 - Chiral library screen